GB0400802D0 - Compounds for the treatment of disease - Google Patents

Compounds for the treatment of disease

Info

Publication number
GB0400802D0
GB0400802D0 GB0400802A GB0400802A GB0400802D0 GB 0400802 D0 GB0400802 D0 GB 0400802D0 GB 0400802 A GB0400802 A GB 0400802A GB 0400802 A GB0400802 A GB 0400802A GB 0400802 D0 GB0400802 D0 GB 0400802D0
Authority
GB
United Kingdom
Prior art keywords
disease
compounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0400802A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daniolabs Ltd
Original Assignee
Daniolabs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daniolabs Ltd filed Critical Daniolabs Ltd
Priority to GB0400802A priority Critical patent/GB0400802D0/en
Publication of GB0400802D0 publication Critical patent/GB0400802D0/en
Priority to PCT/GB2005/000119 priority patent/WO2005067931A2/en
Priority to PCT/GB2005/000118 priority patent/WO2005067930A2/en
Ceased legal-status Critical Current

Links

GB0400802A 2004-01-14 2004-01-14 Compounds for the treatment of disease Ceased GB0400802D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0400802A GB0400802D0 (en) 2004-01-14 2004-01-14 Compounds for the treatment of disease
PCT/GB2005/000119 WO2005067931A2 (en) 2004-01-14 2005-01-14 Dopamine uptake inhibitors for the treatment of neurological disease
PCT/GB2005/000118 WO2005067930A2 (en) 2004-01-14 2005-01-14 Serotonin receptor antagonists for the treatment of neurological disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0400802A GB0400802D0 (en) 2004-01-14 2004-01-14 Compounds for the treatment of disease

Publications (1)

Publication Number Publication Date
GB0400802D0 true GB0400802D0 (en) 2004-02-18

Family

ID=31726178

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0400802A Ceased GB0400802D0 (en) 2004-01-14 2004-01-14 Compounds for the treatment of disease

Country Status (2)

Country Link
GB (1) GB0400802D0 (en)
WO (2) WO2005067930A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007065713A2 (en) * 2005-12-08 2007-06-14 Axxonis Pharma Gmbh Use of 8-alpha-ergolines for the treatment of traumatic brain disorders
US20120028992A1 (en) * 2010-08-02 2012-02-02 Brown Arthur M Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
JP2016503795A (en) * 2012-12-21 2016-02-08 マップ ファーマシューティカルズ インコーポレイテッド Novel methysergide derivatives
WO2015119938A1 (en) * 2014-02-05 2015-08-13 Chanrx Corporation Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia, and/or maintaining normal sinus rhythm in mammals
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
WO2020212948A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
GB201911024D0 (en) * 2019-08-01 2019-09-18 Beckley Found Compounds for use in a method of treating or preventing neurological and/or psychiatric disorders

Also Published As

Publication number Publication date
WO2005067930A3 (en) 2006-02-23
WO2005067931A2 (en) 2005-07-28
WO2005067930A2 (en) 2005-07-28
WO2005067931A3 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
ZA200808178B (en) Imidazolothiazole compounds for the treatment of disease
IL227841A0 (en) Dihydropteridinones for the treatment of cancer diseases
IL195571A0 (en) Compounds for the treatment of periodontal disease
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
GB0423554D0 (en) Therapeutic compounds
IL179145A0 (en) Therapeutic compounds
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
IL178815A0 (en) The treatment of respiratory disease
EP1789034A4 (en) Compounds with diphenoyl -structure for the treatment of immune diseases
GB0329874D0 (en) Compounds useful for the treatment of diseases
GB0410399D0 (en) The treatment of respiratory disease
GB0420424D0 (en) Therapeutic compounds
HK1097831A1 (en) Benzopyran compounds useful for the treatment of arrhytmia
GB0400802D0 (en) Compounds for the treatment of disease
ZA200606780B (en) Compounds for the treatment of diseases
GB0427138D0 (en) Therapeutic compounds
GB0415352D0 (en) Compounds for the treatment of disease
AP2006003743A0 (en) Compounds useful for the treatment of diseases
GB0425064D0 (en) Compounds useful for the treatment of diseases
GB0420867D0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0423767D0 (en) Therapeutic compounds
GB0417560D0 (en) Therapeutic compounds
GB0315877D0 (en) Compounds for the treatment of disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)